Ann: Directors' Report & Financial Report for YE 30 June 2014, page-16

I would expect the prospect of "irrational exuberance " has been drained out of this stock a long time ago to be replaced with a great degree of caution. Of course there will be a lift prior to a possibly good announcement, possibly fueled by new players who haven't witnessed the last few years. On confirmation of the CE mark,( which is not a given and I for one have based my planning on extra questions based on the principle that with this company it has been a case of what can go wrong will, with interest,) then you should see a solid lift. But even then it has to prove itself in the market place that it is indeed as effective as it is made out to be. If it does then it will go. You cant take it at face value anything "they have said" but if it turns out for once to be as it is portrayed then it may be a wonderful ride for investors and patients.